Anticipating and rapidly responding to respiratory virus outbreaks with continuous air sampling in K-12 schools
Project Number5R01AI170737-03
Former Number1R01AI170737-01
Contact PI/Project LeaderO'CONNOR, DAVID H. Other PIs
Awardee OrganizationUNIVERSITY OF WISCONSIN-MADISON
Description
Abstract Text
Project summary/abstract
COVID-19 revealed weaknesses in respiratory pathogen surveillance. Tools to detect SARS-CoV-2 were
initially limited. Now that SARS-CoV-2 is prevalent, schools and other congregate settings struggle to
perform systematic surveillance. As influenza virus and other respiratory pathogens return to co-exist
alongside SARS-CoV-2, pandemic fatigue undermines risk mitigation strategies that rely on behavior
modification, creating an unprecedented risk of illness-caused absenteeism in schools.
We hypothesize that frequent air sampling in K-12 schools is a simple, inexpensive, and accurate sur-
veillance strategy for identifying when schools and the communities where they are located are at high
risk for SARS-CoV-2 and influenza virus transmission.
In this study, we will place an air sampler inside each of 16 K-12 schools and collect continuous air sam-
ples twice weekly throughout the school year. We will test air samples for SARS-CoV-2 and influenza vi-
rus, the two leading causes of respiratory virus absenteeism. A key question is whether detecting these
viruses in air samples is non-inferior to comprehensive individual testing of people with influenza-like
illnesses. We are partnering with the Oregon (Wisconsin) School District which already performs in-
school rapid diagnostic testing of symptomatic individuals. Within this unique setting, we can determine
if the detection rates of SARS-CoV-2 and influenza are similar between air surveillance and diagnostic
testing of individuals. If they are similar, this would suggest that simple, inexpensive, and anonymous
air sampling programs could be the foundation of school-based sentinel virus surveillance programs.
We will also determine whether detecting and sequencing SARS-CoV-2 in air samples forecasts broader
community disease spread. Using SARS-CoV-2 diagnostic testing, wastewater, environmental, and mo-
bility data alongside in-school air sampler detection and sequencing data, we will develop and iterate a
model using air sampler data to forecast community transmission. We will extend this model to forecast
the risk for influenza viruses that are not currently surveilled systematically.
Successfully developing precision air sampler surveillance for SARS-CoV-2 and influenza virus in a large
public school setting would provide a model for a nationwide surveillance program. Such a program
would lead to safer classrooms, improve awareness of respiratory viruses that threaten specific commu-
nities, and increase resilience to respiratory pathogens that threaten schools in the future.
Public Health Relevance Statement
Project narrative
We have shown that air samplers in schools detect respiratory viruses, including SARS-CoV-2 and in-
fluenza viruses. This project will deploy air samplers to 16 K-12 schools to explore whether air sampling
accurately assesses SARS-CoV-2 and influenza virus risk in schools and forecasts transmission of these
viruses in the communities where the schools are located. Viral sequencing of air samples will also be
performed to ascertain which viral variants are circulating and spreading within and between schools
and the broader community.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
161202122
UEI
LCLSJAGTNZQ7
Project Start Date
18-January-2023
Project End Date
31-December-2027
Budget Start Date
01-January-2025
Budget End Date
31-December-2025
Project Funding Information for 2025
Total Funding
$774,809
Direct Costs
$518,824
Indirect Costs
$255,985
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Allergy and Infectious Diseases
$774,809
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI170737-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI170737-03
Patents
No Patents information available for 5R01AI170737-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI170737-03
Clinical Studies
No Clinical Studies information available for 5R01AI170737-03
News and More
Related News Releases
No news release information available for 5R01AI170737-03
History
No Historical information available for 5R01AI170737-03
Similar Projects
No Similar Projects information available for 5R01AI170737-03